2023
DOI: 10.1016/j.drugpo.2023.103953
|View full text |Cite
|
Sign up to set email alerts
|

A population-based study on the risk of prescription opioid abuse in patients with chronic opioid use and cost-effectiveness of prescription drug monitoring program using a patient simulation model in South Korea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
0
0
0
Order By: Relevance
“…In line with our results, Rice et al reported that frequent NIOA prescription was the strongest risk factor of OUD occurrence in prescription opioid users (aOR 6.85, 95% CI 5.98-7.85) (Rice et al 2012). Medical aid (adjusted hazard ratio 1.13, 95% CI 1.07-1.19) was also reported as a significant risk factor in another study in Korea (Kim and Suh 2023). Common medication classes concomitantly misused in patients with OUD are sedatives, hypnotics, or anxiolytics.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…In line with our results, Rice et al reported that frequent NIOA prescription was the strongest risk factor of OUD occurrence in prescription opioid users (aOR 6.85, 95% CI 5.98-7.85) (Rice et al 2012). Medical aid (adjusted hazard ratio 1.13, 95% CI 1.07-1.19) was also reported as a significant risk factor in another study in Korea (Kim and Suh 2023). Common medication classes concomitantly misused in patients with OUD are sedatives, hypnotics, or anxiolytics.…”
Section: Discussionsupporting
confidence: 92%
“…Therefore, to define the OUD case, we used www.journal-dtt.org the ICD-10 codes (F11), which had more than 90% positive predictive value (96.3%, 95% CI 90.8-98.6), although the sensitivity was moderate (42.6%, 95% CI 36.3-49.1) (Campanile and Silverman 2022). Among the known risk factors for OUD, benzodiazepine use, opioid dose, economic status, and frequent NIOA prescriptions were re-confirmed in this study (Rice et al 2012;Cragg et al 2019;Kim and Suh 2023). In line with our results, Rice et al reported that frequent NIOA prescription was the strongest risk factor of OUD occurrence in prescription opioid users (aOR 6.85, 95% CI 5.98-7.85) (Rice et al 2012).…”
Section: Discussionsupporting
confidence: 91%